ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,209.50
0.21%
S&P ASX All Technology
3,408.20
0.78%
Brent Oil
74.135
-0.25%
US Dollar vs AUD
1.47059
0.13%
Bitcoin
63,145.36
0.31%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Silverback Therapeutics Inc (SBTX) Share Price

Silverback Therapeutics Inc

Silverback Therapeutics Inc (SBTX)

Skinbiotherapeutics Plc
5.87
0.00
(0.00%)
At close: 21 September 6:00AM
Delayed by 15 minutes
5.87
0.00
( 0.00% )
After Hours: -
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
5.87
Bid
2.37
Offer
6.15
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
563.502M
Previous Close
5.87
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
95,997,000
Dividend Yield
-
PE Ratio
-26.10
Earnings Per Share (EPS)
-0.57
Revenue
30k
Net Profit
-54.37M

About Silverback Therapeutics Inc

Silverback Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on leveraging its ImmunoTAC technology platform to develop tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. Silverback Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on leveraging its ImmunoTAC technology platform to develop tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
ars-pharma.com
Headquarters
Wilmington, Delaware, USA
Founded
-

Ask ADVFN Intelligence (AI)

SBTX Latest News

More News

ARS Pharmaceuticals Announces Presentation of Data Supporting neffy (epinephrine nasal spray) and Real-World Burden of Needle Injectors

Data to be Presented in Five Poster Presentations at the 2023 American Academy of Allergy, Asthma and Immunology Annual Meeting Data Support New Drug Application for neffy®, Currently Under Review...

24 February 2023
GlobeNewswire Inc.

ARS Pharmaceuticals Reacquires European Marketing Rights to neffy® (ARS-1) for the Treatment of Type I Allergic Reactions Including Anaphylaxis

SAN DIEGO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect...

23 February 2023
GlobeNewswire Inc.

ARS Pharmaceuticals to Participate in the SVB Securities Virtual Global Biopharma Conference 2023

SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect...

09 February 2023
GlobeNewswire Inc.

ARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including Anaphylaxis

Data from Pivotal Clinical Trials to be Presented in Five Poster Presentations at the 2022 American College of Allergy, Asthma and Immunology Annual Scientific Meeting Data Support New Drug...

11 November 2022
GlobeNewswire Inc.

ARS Pharmaceuticals Closes Merger with Silverback Therapeutics

Over $280 Million in Combined Cash and Securities and at least Three Years Operating Runway to Support Launch and Commercialization of neffy® in the U.S., if Approved neffy® NDA Currently Under...

09 November 2022
GlobeNewswire Inc.

Silverback Therapeutics' Nasal Spray for Allergic Reactions Gets FDA Review Approval

By Sabela Ojea Silverback Therapeutics Inc. said Friday that the U.S. Food and Drug Administration has accepted for review its new drug application for Neffy, an emergency nasal spray to treat...

21 October 2022
Dow Jones News

Silverback Therapeutics, Inc. announces the FDA’s acceptance of ARS Pharmaceuticals’ NDA for neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (type I) including Anaphylaxis

neffy has potential to be the first non-injectable medicine indicated to treat allergic reactions (type I) including anaphylaxis in the U.S., if approved Silverback Therapeutics, Inc. (Nasdaq:...

21 October 2022
Business Wire

Silverback Therapeutics and ARS Pharmaceuticals Announce Merger

Transaction to support potential commercialization of neffy™, ARS’s needle-free epinephrine nasal spray Well-funded with at least three years of operating runway expected Companies to host...

22 July 2022
Business Wire

Silverback Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”), a biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered, tissue...

18 May 2022
Business Wire

Silverback Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update

Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”), a biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered, tissue...

13 May 2022
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JSPRWJasper Therapeutics Inc
US$ 0.3333
(66.65%)
202
TGLTreasure Global Inc
US$ 1.0799
(58.74%)
1.86M
ULYUrgent ly Inc
US$ 1.18
(33.77%)
7.61M
NUKKNukkleus Inc
US$ 0.2751
(29.46%)
10.61M
NVVENuvve Holding Corporation
US$ 4.60
(17.35%)
7.48k
ZJYLJin Medical International Ltd
US$ 2.88
(-29.41%)
224.34k
PRFXPainReform Ltd
US$ 0.599
(-22.32%)
294.67k
MYNZMainz BioMed NV
US$ 0.202575
(-16.64%)
1.71M
ADTXAditxt Inc
US$ 0.32
(-16.36%)
6.07M
CJETChijet Motor Company Inc
US$ 2.358
(-15.79%)
113.32k
NVDANVIDIA Corporation
US$ 116.15
(0.13%)
14.13M
NUKKNukkleus Inc
US$ 0.2751
(29.46%)
10.61M
MAXNMaxeon Solar Technologies Ltd
US$ 0.0856
(-6.45%)
10.36M
XPONExpion360 Inc
US$ 0.0788
(-7.08%)
10.1M
INTCIntel Corporation
US$ 21.99
(0.69%)
7.88M

Discussion

View Full Feed
1vman 1vman 3 minutes ago
***** ALERT !!! OMHE STILL_ON_THE_EXPERT_MARKET

ENOUGH SAID
OMHE
manibiotech manibiotech 3 minutes ago
“ROI includes patient lives changed for the better. Others here share the same view. Best wishes.”

Here you clearly imply others meaning all others except you in common English . I don’t see “ some of us “ or “ many of us “ .

You start bringing up irrelevant and nonsens
NWBO
Dead On Arrival Dead On Arrival 3 minutes ago
Which stock and company is the most credible at the moment:

1)Truth

2) LWLG

3)Niocorp

4)All of the above. They are all garbage.
LWLG
Batman412 Batman412 3 minutes ago
This hits .005 and all that waiting will pay
TONR
redwagon redwagon 3 minutes ago
Will you be mad if I win with Dryworld? Will you be glad to be wrong and that all us “suckers” ending up winning? Happy that there was an actual real company to make it out of the OTC swamp?
IBGR
fuagf fuagf 4 minutes ago
dbergh, If you are going to use the quote function at least use it properly. Suggest you put your added message first then put the bit you are repeating as a quote beneath it. You have put all of mine and your added as if is all in the same quote. Personally i use "..." and italics for quotes (when
Schrodingers Cat Schrodingers Cat 5 minutes ago
Sep 20 short volumes: CODX 44%, FLGT 44%, QDEL 58%, VERU 63%.
CODX VERU
germansaer germansaer 5 minutes ago
https://www.courtlistener.com/docket/4212077/fairholme-funds-inc-v-federal-housing-finance-agency/?order_by=desc
FNMA
Seriously123 Seriously123 5 minutes ago
Ok so the stalker says...

That posts non stop and goes back years on my posts. Lol

So impressive that you are so interested in me too.
SFRX
al44 al44 7 minutes ago
No Larry, they haven't. But anyone with half a brain can see it plainly. That says a lot about the leftists that deny it.

........................al
stealofadeal stealofadeal 8 minutes ago
$GEVI Steve Conboy will get this stock over 20.00 and uplist. Conboy brings a lot to the table here.
GEVI
neomania neomania 8 minutes ago
lol the app has been getting fine tuned for months WIZZ knows all about it
NSAV
getmoreshares getmoreshares 8 minutes ago
palladium was not listed in the report.
NBRI
Aero-man Aero-man 8 minutes ago
Sadly, board shit-heads, docsetc, jerk-n-hard & squidster, have had their collective bung-holes reamed out in one of their past ventures that went south - get over it already. Move on whack-jobs, you accomplish ZERO here.
HALB
newflow newflow 9 minutes ago
Lotas why there 4 EC members on TAB of WMILT thru Jan 2020 and why were two insiders were appointed as administrators, why did Kosturos go?.
Why RALTA is a non public document?.
Why did Mr.Nelson wanted control of WMILT after the claims were paid?.
Why did THJMW signed a documen
COOP
Doc logic Doc logic 9 minutes ago
JTORENCE,

Very likely true about what the Chinese would have done. Best wishes.
NWBO
wadegarret wadegarret 9 minutes ago
R59- VIK

What do you think of this one. At quick glance, it appears analysts expect 40%+ growth next year, and the stock sells for a `17 PE gf. Seems a significantly better peg ratio than their peers.
CommodityCoverage CommodityCoverage 11 minutes ago
Luca Mining (LUCA.v, LUCMF) is "On the Path Towards 100,000 Gold Equivalent Ounces by 2025" from its two key assets in Mexico, the producing Campo Morado and near-term producing Tahuehueto: https://x.com/StckMasterFlash/status/1836164135085830340

Providing a natural hedge gold, coppe
LUCMF
KCCO7913 KCCO7913 12 minutes ago
https://www.youtube.com/watch?v=ig4jbcU9db0
LWLG
1vman 1vman 12 minutes ago
***** NOPE ! The plant is long gone and has zero to do with NRDE ( Pu ride ) , whoops

ENOUGH SAID
NRDE
Hitman970 Hitman970 12 minutes ago
https://pitchbook.com/profiles/investor/226823-68#overview

Do your own DD!!!$$$
AASP
Jay_B Jay_B 13 minutes ago
I believe SFLM absolutely will run again.... WHEN/IF the mysterious Chadbominable Yeti comes out of his hidey-hole and addresses his shareholders with some hint of progress on his "new business plan".
SFLM
Saving Grace Saving Grace 13 minutes ago
Plant will return to LMC/NU Ride Inc. as Foxconn defaulted on $170,000,000 payment.

NU Ride Lawsuit against Foxconn exceeds 5.2Billion in damages.

This is far from over and will be just the beginning of a massive conglomerate.

Lordstown had taken over th
NRDE
lakers17 lakers17 14 minutes ago
Amazing isn't it? Knoll, Tilton and this Mike guy know their fool audience here and on Discord and podcasts. These few have no clue how the OTC really works and will believe and listen to anything these NSAV suspect guys put out. How much are they down now while waiting for .06 and dollars? Fort
NSAV

Your Recent History

NASDAQ
SBTX
Silverback Therapeutics
NASDAQ
PAYO
Payoneer Global
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved